Cargando…
HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia
Allogeneic hematopoietic stem cell transplantation (HSCT) is still needed for many children with very high-risk acute leukemia. An HLA-haploidentical family donor is a suitable option for those without an HLA-matched donor. Here we present outcomes of a novel HLA-haploidentical HSCT (haplo-HSCT) str...
Autores principales: | Massei, M. S., Capolsini, I., Mastrodicasa, E., Perruccio, K., Arcioni, F., Cerri, C., Gurdo, G., Sciabolacci, S., Falzetti, F., Zei, T., Iacucci Ostini, R., Brogna, M., Panizza, B. M., Saldi, S., Merluzzi, M., Tognellini, R., Marchesi, M., Minelli, O., Aristei, C., Velardi, A., Pierini, A., Ruggeri, L., Martelli, M. F., Carotti, A., Caniglia, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919737/ https://www.ncbi.nlm.nih.gov/pubmed/36774432 http://dx.doi.org/10.1038/s41409-023-01911-x |
Ejemplares similares
-
Sirolimus-Based Immunosuppression as GvHD Prophylaxis after Bone Marrow Transplantation for Severe Aplastic Anaemia: A Case Report and Review of the Literature
por: Perruccio, Katia, et al.
Publicado: (2015) -
Case Report: Remdesivir and Convalescent Plasma in a Newly Acute B Lymphoblastic Leukemia Diagnosis With Concomitant Sars-CoV-2 Infection
por: Dell'Isola, Giovanni Battista, et al.
Publicado: (2021) -
Acute lymphoblastic leukemia relapse presenting with optic nerve
infiltration
por: Dini, Gianluca, et al.
Publicado: (2023) -
Blinatumomab Redirects Donor Lymphocytes against CD19(+) Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation
por: Mancusi, Antonella, et al.
Publicado: (2023) -
PB2442: BLINATUMOMAB REDIRECTS DONOR LYMPHOCYTES AGAINST CD19+ ALL WITHOUT INCREASING THE RISK OF BYSTANDER ALLOREACTIVITY AFTER HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION
por: Mancusi, Antonella, et al.
Publicado: (2023)